# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4031384 | B | Inhibition of FLT3 in human MOLM14 cells assessed as inhibition of FLT3 autophosphorylation at Tyr589/591 site at 1 nM after 4 hrs by immunoblotting analysis | Homo sapiens | 1 | ALA4028866 | cell-based format | Scientific Literature | |
2. | ALA4031385 | F | Antiproliferative activity against mouse BAF3 cells harboring FLT3-D835Y mutation after 72 hrs by CellTiter-Glo assay | Mus musculus | 2 | ALA4028866 | cell-based format | Scientific Literature | |
3. | ALA4031386 | B | Inhibition of human FLT3 (V592 to Y969 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
4. | ALA4031387 | B | Inhibition of human FLT3 D835H mutant (V592 to Y969 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
5. | ALA4031388 | B | Inhibition of human FLT3 ITD mutant expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
6. | ALA4031389 | B | Inhibition of human FLT3 K663Q mutant (V592 to Y969 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
7. | ALA4031390 | B | Inhibition of human FLT3 R834Q mutant (V592 to Y969 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
8. | ALA4031391 | B | Inhibition of human CDK7 (M1 to L344 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
9. | ALA4031392 | B | Inhibition of human CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
10. | ALA4031393 | B | Inhibition of human CDK11 (M1 to T360 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
11. | ALA4031394 | B | Inhibition of human CDKL2 (M1 to D327 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
12. | ALA4031395 | B | Inhibition of human CIT (M68 to E432 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
13. | ALA4031396 | B | Inhibition of human CSF1R (I564 to S939 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
14. | ALA4031397 | B | Inhibition of human DDR1 (R565 to V876 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
15. | ALA4031398 | B | Inhibition of human DDR2 (V555 to E855 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
16. | ALA4031399 | B | Inhibition of human FLT4 (E821 to E1196 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
17. | ALA4031400 | B | Inhibition of human KIT (I571 to D952 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
18. | ALA4031401 | B | Inhibition of human LCK (R207 to P509 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
19. | ALA4031402 | B | Inhibition of human LOK (E16 to V314 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature | |
20. | ALA4031403 | B | Inhibition of human MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control | Homo sapiens | 1 | ALA4028866 | assay format | Scientific Literature |